0026-895X/04/6601-187-196$20.00
Mol Pharmacol 66:187-196, 2004
Activation of Phosphoinositide 3-kinase in Response to High Glucose Leads to Regulation of Reactive Oxygen Species-Related Nuclear Factor-
B Activation and Cyclooxygenase-2 Expression in Mesangial Cells
Meei Ling Sheu,
Feng Ming Ho,
Kuo Fang Chao,
Ming Liang Kuo, and
Shing Hwa Liu
Institute of Toxicology, College of Medicine, National Taiwan University, Taipei, Taiwan (M.L.S., K.F.C., M.L.K., S.H.L.); and Department of Nursing, Chung-Tai Institute of Health Sciences and Technology, Taichung, Taiwan (F.M.H.)
Hyperglycemia causes glomerular mesangial cell proliferation and increases matrix synthesis, contributing to early diabetic glomerulopathy. Immunohistochemical and functional correlations of renal cyclooxygenase-2 in experimental diabetes have been identified. However, the role of cyclooxygenase-2 in early diabetes-induced mesangial cell proliferation remains unknown. The authors tested the hypothesis that hyperglycemia modulates an intrarenal cyclooxygenase-2 expression, which might mediate the mesangial cell proliferation via a possible phosphoinositide 3-kinase/Akt pathway. Expression of cyclooxygenase-2, but not cyclooxygenase-1, could be induced in mesangial cells cultured under high glucose. Antioxidants (pyrrolidine dithiocarbamate and N-acetyl-L-cysteine) and phosphoinositide 3-kinase inhibitors [2-(4-morpholinyl)-8-phenyl-1(4H)-benzopyran-4-one hydrochloride (LY294002) and wortmannin] effectively inhibited this high glucose-induced response. Moreover, high glucose markedly triggered the activation of phosphoinositide 3-kinase and Akt in mesangial cells, suggesting that a phosphoinositide 3-kinase/Akt pathway is involved in the high glucose-induced responses. Phosphoinositide 3-kinase inhibitors could also effectively attenuate the high glucose-triggered intracellular reactive oxygen species generation and nuclear factor-
B activation. Likewise, blocking the phosphoinositide 3-kinase or Akt activity with the dominant-negative vectors DN-p85 or DN-Akt, respectively, also greatly diminished the high glucose-triggered reactive oxygen species generation and nuclear factor-
B activation. Treatment of mesangial cells with LY294002 and cyclooxygenase-2 inhibitors [N-[2-(cyclohexyloxyl)-4-nitrophenyl]-methane sulfonamide (NS398) and aspirin] effectively inhibited the high glucose-induced mesangial cell proliferation. These results suggest that high glucose may trigger the reactive oxygen species-regulated nuclear factor-
B activation and cyclooxygenase-2 expression and cell proliferation in mesangial cells through a phosphoinositide 3-kinase-dependent pathway.
Received September 4, 2003;
accepted April 14, 2004
Address correspondence to: Dr. Shing-Hwa Liu, Institute of Toxicology, College of Medicine, National Taiwan University, 1, Section 1, Jen-Ai Road, Taipei, 10043, Taiwan. E-mail: shliu{at}ha.mc.ntu.edu.tw
This article has been cited by other articles:

|
 |

|
 |
 
S. Simone, Y. Gorin, C. Velagapudi, H. E. Abboud, and S. L. Habib
Mechanism of Oxidative DNA Damage in Diabetes: Tuberin Inactivation and Downregulation of DNA Repair Enzyme 8-Oxo-7,8-Dihydro-2'-Deoxyguanosine-DNA Glycosylase
Diabetes,
October 1, 2008;
57(10):
2626 - 2636.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Venkatachalam, S. Mummidi, D. M. Cortez, S. D. Prabhu, A. J. Valente, and B. Chandrasekar
Resveratrol inhibits high glucose-induced PI3K/Akt/ERK-dependent interleukin-17 expression in primary mouse cardiac fibroblasts
Am J Physiol Heart Circ Physiol,
May 1, 2008;
294(5):
H2078 - H2087.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. C. Chuang, R. S. Yang, K. S. Tsai, F. M. Ho, and S. H. Liu
Hyperglycemia Enhances Adipogenic Induction of Lipid Accumulation: Involvement of Extracellular Signal-Regulated Protein Kinase 1/2, Phosphoinositide 3-Kinase/Akt, and Peroxisome Proliferator-Activated Receptor {gamma} Signaling
Endocrinology,
September 1, 2007;
148(9):
4267 - 4275.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. S. Barbieri and B. B. Weksler
Tobacco smoke cooperates with interleukin-1{beta} to alter {beta}-catenin trafficking in vascular endothelium resulting in increased permeability and induction of cyclooxygenase-2 expression in vitro and in vivo
FASEB J,
June 1, 2007;
21(8):
1831 - 1843.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. W. Chen, C. F. Huang, K. S. Tsai, R. S. Yang, C. C. Yen, C. Y. Yang, S. Y. Lin-Shiau, and S. H. Liu
The Role of Phosphoinositide 3-Kinase/Akt Signaling in Low-Dose Mercury-Induced Mouse Pancreatic {beta}-Cell Dysfunction In Vitro and In Vivo
Diabetes,
June 1, 2006;
55(6):
1614 - 1624.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N.-H. Kim, H. Rincon-Choles, B. Bhandari, G. G. Choudhury, H. E. Abboud, and Y. Gorin
Redox dependence of glomerular epithelial cell hypertrophy in response to glucose
Am J Physiol Renal Physiol,
March 1, 2006;
290(3):
F741 - F751.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. A. Finlay, V. J. Thannickal, B. L. Fanburg, and D. J. Kwiatkowski
Platelet-Derived Growth Factor-Induced p42/44 Mitogen-Activated Protein Kinase Activation and Cellular Growth Is Mediated by Reactive Oxygen Species in the Absence of TSC2/Tuberin
Cancer Res.,
December 1, 2005;
65(23):
10881 - 10890.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Gorin, K. Block, J. Hernandez, B. Bhandari, B. Wagner, J. L. Barnes, and H. E. Abboud
Nox4 NAD(P)H Oxidase Mediates Hypertrophy and Fibronectin Expression in the Diabetic Kidney
J. Biol. Chem.,
November 25, 2005;
280(47):
39616 - 39626.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Li and K. U. Malik
Angiotensin II-induced Akt activation is mediated by metabolites of arachidonic acid generated by CaMKII-stimulated Ca2+-dependent phospholipase A2
Am J Physiol Heart Circ Physiol,
May 1, 2005;
288(5):
H2306 - H2316.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Sheu, F. M. Ho, R. S. Yang, K. F. Chao, W. W. Lin, S. Y. Lin-Shiau, and S.-H. Liu
High Glucose Induces Human Endothelial Cell Apoptosis Through a Phosphoinositide 3-Kinase-Regulated Cyclooxygenase-2 Pathway
Arterioscler. Thromb. Vasc. Biol.,
March 1, 2005;
25(3):
539 - 545.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics